These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38517555)

  • 1. TRIM5 as a promising diagnostic biomarker of hepatocellular carcinoma: integrated analysis and experimental validation.
    Liu H; Tang Y; Zhang J; Wu G; Peng Q; Chen C; Cao J; Peng R; Su B; Tu D; Jiang G; Wang Q; Liu R; Wang A; Jin S; Zhang C; Bai D
    Funct Integr Genomics; 2024 Mar; 24(2):63. PubMed ID: 38517555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
    Chen Y; Li Q; Zhang J; Gu R; Li K; Zhao G; Yuan H; Feng T; Ou D; Lin P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Jun; 37(3):469-479. PubMed ID: 32597089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma.
    Chen J; Gao G; Zhang Y; Dai P; Huang Y
    BMC Cancer; 2023 Sep; 23(1):899. PubMed ID: 37743471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.
    Lu J; Liang K; Zou R; Peng Y; Wang H; Huang R; Zeng Z; Feng Z; Fan Y; Zhang S; Ji Y; Pang X; Wang Y; Zhang H; Wang Z
    Aging (Albany NY); 2023 Jun; 15(12):5798-5825. PubMed ID: 37367937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.
    Wu L; Yin X; Jiang K; Yin J; Yu H; Yang L; Ma C; Yan S
    Cancer Med; 2022 Apr; 11(7):1712-1731. PubMed ID: 35142083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
    Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
    J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration.
    Nong JS; Zhou X; Liu JQ; Luo JZ; Huang JM; Xie HX; Yang KJ; Wang J; Ye XP; Peng T
    Cancer Med; 2023 May; 12(9):10990-11009. PubMed ID: 36952458
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
    Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 13. ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma.
    Liu X; He Y; Wang P; Hu J; Hao C; Wang Q; Yang Y; Sun Y; Ma B; Sun H; Xue D; Meng X
    Dis Markers; 2022; 2022():5791471. PubMed ID: 35280441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma.
    Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L
    Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of immune infiltrates and tripartite motif (
    Cao J; Su B; Peng R; Tang H; Tu D; Tang Y; Zhou J; Jiang G; Jin S; Wang Q; Wang A; Liu R; Deng Q; Zhang C; Bai D
    J Gastrointest Oncol; 2022 Aug; 13(4):1942-1958. PubMed ID: 36092338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
    Jin W; Wang G; Dong M; Wang X
    Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STARD5 as a potential clinical target of hepatocellular carcinoma.
    Liu Q; Du X; Yu Z; Yao Q; Meng X; Zhang K; Zheng L; Hong W
    Med Oncol; 2022 Jul; 39(10):156. PubMed ID: 35852638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
    Hou Y; Zhang G
    Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.